Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07707375 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of LY4268989 (MORF 057) in Healthy Participants

Name: A Study of LY4268989 (MORF 057) in Healthy Participants — clinical trial record (NCT07707375)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 1

SponsorEli Lilly and Company

Started2026-07-20

View on ClinicalTrials.gov ↗

The purpose of this study is to identify if two different tablets of LY4268989 (MORF 057) work similarly in healthy participants given different meals. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. There will be 18 inpatient stays at the clinical research unit (CRU). The study will last about 9 weeks.

Amendment history 1 change detected by DataLookout

2026-08-21

Recruitment opened

Trial Details

NCT Number	NCT07707375
Lead Sponsor	Eli Lilly and Company
Conditions	Healthy
Enrollment	50 participants
Start Date	2026-07-20
Primary Completion	2026-10 (estimated)
Study Completion	2026-10 (estimated)
Updated on ClinicalTrials.gov	2026-08-20